Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.42), $0.04 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $12.53 million versus the consensus estimate of $5.7 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.